Skip to content

13F-HR filed by Melqart Asset Management (UK) Ltd

Melqart Asset Management (UK) Ltd filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 27 holding rows worth $1,101,160,000.

Accession
0001172661-19-002305
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 27 entries on the cover page, a total value of $1,101,160,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,101,160,000 with VALUE read as thousands by filing date, 13F file number 028-18520. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM1,451,000$144,084,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock1,050,000$114,576,000thousands by filing date
ALLERGAN PLCG0177J108SHS608,700$102,438,000thousands by filing date
CYPRESS SEMICONDUCTOR CORP232806109COM3,823,000$89,229,000thousands by filing date
ZAYO GROUP HLDGS INC COM98919V105Stock2,201,000$74,614,000thousands by filing date
MELLANOX TECHNOLOGIES LTDM51363113COMMON STOCK628,391$68,865,000thousands by filing date
WABCO HLDGS INC92927K102COM383,000$51,226,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM2,680,000$50,545,000thousands by filing date
VERSUM MATLS INC92532W103COM890,000$47,108,000thousands by filing date
NIELSEN HOLDINGS PLCG6518L108SHS EUR1,701,161$36,150,000thousands by filing date
AVAYA HLDGS CORP05351X101COM3,512,988$35,938,000thousands by filing date
CYRUSONE INC23283R100COM398,600$31,529,000thousands by filing date
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR1,672,350$28,764,000thousands by filing date
INTELSAT S AL5140P101COM1,231,500$28,078,000thousands by filing datecall
ACACIA COMMUNICATIONS INC00401C108COM414,579$27,113,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM160,000$27,107,000thousands by filing date
PRESIDIO INC74102M103COM1,457,155$24,626,000thousands by filing date
QIWI PLC74735M108SPON ADR REP B1,023,639$22,469,000thousands by filing date
ATLANTICA YIELD PLCG0751N103SHS869,936$20,957,000thousands by filing date
CONTURA ENERGY INC21241B100COM549,115$15,353,000thousands by filing date
ATLASSIAN CORPG06242104CL A107,000$13,422,000thousands by filing date
TWILIO INC CL A90138F102Stock120,000$13,195,000thousands by filing date
RINGCENTRAL INC76680R206CL A103,234$12,972,000thousands by filing date
QUINTANA ENERGY SVCS INC74875T103COM3,288,449$6,708,000thousands by filing date
FIVE9 INC338307101COM115,000$6,180,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK529,112$5,696,000thousands by filing date
AVAYA HLDGS CORP05351XAB7NOTE 2.250% 6/12,600,000$2,218,000thousands by filing dateprincipal

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-19-002305this filing2019-11-14acceptance time not in the bulk data set